Clal Insurance Enterprises (CLIS) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
10 Nov, 2026Executive summary
H1 2025 comprehensive income attributable to shareholders was NIS 941m versus NIS 925m; excluding the Special Provision’s estimated NIS 101m after-tax impact, it was NIS 1,042m.
H1 core income was NIS 1,123m versus NIS 1,113m; annualized ROE was 21.5%, or 23.8% excluding adjustments.
Insurance and Savings underwriting income was NIS 615m before tax; Max H1 net income was NIS 150m excluding the Special Provision.
Financial highlights
H1 income before tax was NIS 1,433m versus NIS 1,399m; net income was NIS 951m versus NIS 923m, and EPS was NIS 11.90 versus NIS 11.65.
Q2 income before tax was NIS 828m versus NIS 918m; net income was NIS 543m versus NIS 608m, and EPS was NIS 6.77 versus NIS 7.68.
Q2 comprehensive income was NIS 531m reported and NIS 632m excluding the Special Provision, versus NIS 610m in Q2 2024.
H1 remaining financial margin rose to NIS 442m from NIS 290m, supported by higher capital-market yields that offset lower risk-free rates and increased insurance liabilities.
Outlook and guidance
Bank of Israel forecasts GDP growth of 3.3% in 2025 and 4.6% in 2026; the budget deficit is forecast at 4.9% and 4.2% of GDP, respectively.
Credit-loss estimates remain judgmental amid uncertainty over the war’s duration, economic impact and customer repayment capacity; future losses could be materially above or below current estimates.
Credit-card issuance and acquiring activity rapidly returned to pre-Operation Rising Lion levels after the 12-day disruption; overseas issuance turnover recovered as flights resumed.
Latest events from Clal Insurance Enterprises
- Markets and P&C gains restored profitability, while health reserves and war uncertainty weighed.CLIS
Q1 2024 - H1 returned to profit on stronger underwriting and card results despite weak markets.CLIS
Q2 2024 - 9M comprehensive income reached NIS 596m, supported by stronger investment returns and underwriting.CLIS
Q3 2024 - 2024 comprehensive income rose to NIS 956m as insurance and MAX expanded earnings.CLIS
Q4 2024 - Q1 earnings rose on stronger underwriting and Max, amid market and war-related uncertainty.CLIS
Q1 2025 - 9M earnings and AUM grew, with results absorbing a one-off VAT provision.CLIS
Q3 2025 - Core income rose 12%; 2025 dividend reached NIS 400M.CLIS
Q4 2025 - Core income rose 13% as insurance and savings growth lifted Q1 results.CLIS
Q1 2026 - H1 earnings and AUM grew, alongside NIS 200M buyback and dividend plans.CLIS
Q2 2026